EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like and HER2 intrinsic subtypes of breast cancer

Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer

(2012) M. Schmidt et al.   ANNALS OF ONCOLOGY

Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective

(2012) F. Penault-Llorca et al.   ANNALS OF ONCOLOGY

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines

(2012) Agnieszka Martowicz et al.   BMC CANCER

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

EpCAM expression is an indicator of recurrence in basal-like breast cancer

(2011) Ayodeji J. Agboola et al.   BREAST CANCER RESEARCH AND TREATMENT

Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer

(2011) Coya Tapia et al.   HUMAN PATHOLOGY

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

(2011) Gilbert Spizzo et al.   JOURNAL OF CLINICAL PATHOLOGY

EpCAM in carcinogenesis: the good, the bad or the ugly

(2010) B. T. F. van der Gun et al.   CARCINOGENESIS

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

(2009) M. Schmidt et al.   ANNALS OF ONCOLOGY

Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion

(2009) N. V. Sankpal et al.   CANCER RESEARCH

Dual Expression Lentiviral Vectors for Concurrent RNA Interference and Rescue

(2009) Narendra V. Sankpal et al.   JOURNAL OF SURGICAL RESEARCH

Nuclear signalling by tumour-associated antigen EpCAM

(2009) Dorothea Maetzel et al.   NATURE CELL BIOLOGY

Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

(2008) M. Schmidt et al.   CLINICAL CANCER RESEARCH